Advice for management of the long-QT patient.
Donahue
J Kevin
JK
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002304:Cardiac Pacing, Artificial; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation; D005838:Genotype; D006323:Heart Arrest / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications / Q000188:drug therapy*; D010641:Phenotype; D018570:Risk Assessment; D012307:Risk Factors; D013575:Syncope / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists